Literature DB >> 19394377

Glucose-responsive gene expression system for gene therapy.

Jong Chul Won1, Byoung Doo Rhee, Kyung Soo Ko.   

Abstract

Regulation of gene expression by glucose is an important mechanism for mammals in adapting to their nutritional environment. Glucose, the primary fuel for most cells, modulates gene expression that is crucial in the cellular adaptation to glycemic variation. Transcription of the genes for insulin and glycolytic and lipogenic enzymes is stimulated by glucose in pancreatic beta-cells and liver. Recent findings further support the key role of the carbohydrate-responsive element binding protein in the regulation of glycolytic and lipogenic genes by glucose and dietary carbohydrates. Herein, we review the transcriptional regulation of glucose-responsive genes, and recent advances in the gene therapy using glucose-responsive gene expression for diabetes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19394377     DOI: 10.1016/j.addr.2009.03.015

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  3 in total

1.  Remission of diabetes by insulin gene therapy using a hepatocyte-specific and glucose-responsive synthetic promoter.

Authors:  Jaeseok Han; Brienne McLane; Eung-Hwi Kim; Ji-Won Yoon; Hee-Sook Jun
Journal:  Mol Ther       Date:  2010-11-30       Impact factor: 11.454

2.  Delivery of a therapeutic protein by immune-privileged Sertoli cells.

Authors:  Katelyn Halley; Emily L Dyson; Gurvinder Kaur; Payal Mital; Peter M Uong; Brinda Dass; Sherry N Crowell; Jannette M Dufour
Journal:  Cell Transplant       Date:  2010-08-17       Impact factor: 4.064

3.  Glucose-responsive artificial promoter-mediated insulin gene transfer improves glucose control in diabetic mice.

Authors:  Jaeseok Han; Eung-Hwi Kim; Woohyuk Choi; Hee-Sook Jun
Journal:  World J Gastroenterol       Date:  2012-11-28       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.